S. Riegelman

发表

Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

M. Rowland, S. Riegelman, J. Loo, 1968, Journal of pharmaceutical sciences.

Pharmaceutical applications of solid dispersion systems.

S. Riegelman, W. L. Chiou, 1971, Journal of pharmaceutical sciences.

Determination of isoniazid and metabolites in biological fluids.

H. Boxenbaum, S. Riegelman, 1974, Journal of pharmaceutical sciences.

Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin.

S. Riegelman, W. L. Chiou, 1969, Journal of pharmaceutical sciences.

Disposition of caffeine and its metabolites in man.

R. Williams, S. Riegelman, D. Tang-Liu, 1983, The Journal of pharmacology and experimental therapeutics.

Absorption kinetics of griseofulvin in man.

M. Rowland, S. Riegelman, W. Epstein, 1968, Journal of pharmaceutical sciences.

Isolation, characterisation and synthesis of a new quinidine metabolite

S. Riegelman, T. Guentert, J. Daly, 2010, European Journal of Drug Metabolism and Pharmacokinetics.

Determination of acetylsalicylic acid and salicylic acid in plasma.

M. Rowland, S. Riegelman, M. Rowland, 1967, Journal of pharmaceutical sciences.

Bacterial Testing of Contact Lens Solutions

S. Riegelman, 1967 .

Intestinal drug absorption and metabolism. II. Kinetic aspects of intestinal glucuronide conjugation.

W. H. Barr, S. Riegelman, 1970, Journal of pharmaceutical sciences.

The properties of iodine in solutions of surface-active agents.

S. Riegelman, N. Allawala, 1953, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration--effect relationships.

L. Sheiner, N. Holford, S. Riegelman, 1981, British Journal of Clinical Pharmacology.

In vivo effects of the cytochrome P-450 suicide substrate 2-isopropyl-4-pentenamide (allylisopropylacetamide) on the disposition and metabolic pattern of propranolol.

P. Ortiz de Montellano, S. Riegelman, B. Silber, 1981, The Journal of pharmacology and experimental therapeutics.

The influence of cigarette smoking and sex on theophylline disposition.

L. Sansom, J. Powell, S. Vožeh, 2015, The American review of respiratory disease.

Evaluation of a modified high-performance liquid chromatography assay for acebutolol and its major metabolite.

S. Riegelman, T. Guentert, R. Upton, 1979, Journal of chromatography.

An automated HPLC assay for simultaneous quantitation of methylated xanthines and uric acids in urine.

S. Riegelman, D. Tang-Liu, 1982, Journal of chromatographic science.

On the mechanism of steroid fluorescence in sulfuric acid. I. The formation of trienones.

W. Sadee, S. Riegelman, L. Johnson, 1971, Steroids.

Renal contribution to overall metabolism of drugs. I. Conversion of benzoic acid to hippuric acid.

S. Riegelman, S. H. Wan, 1972, Journal of pharmaceutical sciences.

Rational Use of Theophylline for Bronchodilatation

S. Riegelman, M. Weinberger, 1974 .

Dependence of renal clearance on urine flow: a mathematical model and its application.

T. Tozer, S. Riegelman, D. Tang-Liu, 1983, Journal of pharmaceutical sciences.

Pharmacokinetics and pharmacodynamics of quinidine and its metabolite, quinidine-N-oxide, in beagle dogs

N. Holford, S. Riegelman, T. Guentert, 1984, European Journal of Drug Metabolism and Pharmacokinetics.

Influence of the route of administration on the area under the plasma concentration-time curve.

S. Riegelman, P. Harris, 1969, Journal of pharmaceutical sciences.

Controlled release theophylline.

S. Riegelman, J. Jenne, 1980, Chest.

Stereoselective disposition and glucuronidation of propranolol in humans.

N. Holford, S. Riegelman, B. Silber, 1982, Journal of pharmaceutical sciences.

Stereospecific assay for (-)- and (+)-propranolol in human and dog plasma.

S. Riegelman, B. Silber, 1980, The Journal of pharmacology and experimental therapeutics.

Acetylsalicylic acid hydrolysis in human blood and plasma. I. Methodology and in vitro studies.

S. Riegelman, P. Harris, 1967, Journal of pharmaceutical sciences.

Urine flow-dependence of theophylline renal clearance in man

T. Tozer, S. Riegelman, D. Tang-Liu, 1982, Journal of Pharmacokinetics and Biopharmaceutics.

Measurement of excretion characteristics of theophylline and its major metabolites

S. Riegelman, R. Upton, J. Jonkman, 2004, European Journal of Clinical Pharmacology.

Selective quantitative determination of methylxanthines and methyluric acids in urine

S. Riegelman, K. Muir, J. Jonkman, 1982 .

Simultaneous determination of theophylline and its major metabolites in urine by reversed-phase ion-pair high-performance liquid chromatography

S. Riegelman, K. Muir, J. Jonkman, 1980 .

Saturation kinetics of iodipamide.

A. Moss, S. Riegelman, S. K. Lin, 1977, Investigative radiology.

Iodipamide kinetics: capacity-limited biliary excretion with simultaneous pseudo-first-order renal excretion.

A. Moss, S. Riegelman, S. K. Lin, 1977, Journal of pharmaceutical sciences.

Metabolism of theophylline to caffeine in adults.

S. Riegelman, D. Tang-Liu, 1981, Research communications in chemical pathology and pharmacology.

Pharmacokinetics of iodoxamic acid in rhesus monkey: biliary excretion, plasma protein binding, and enterophepatic circulation.

A. Moss, S. Riegelman, S. K. Lin, 1978, Journal of pharmaceutical sciences.

Effect of route of administration on drug disposition

M. Rowland, S. Riegelman, 1973, Journal of Pharmacokinetics and Biopharmaceutics.

The release of antimicrobial agents from solutions of surface-active agents.

S. Riegelman, N. Allawala, 1953, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

Pharmacokinetics; Pharmacokinetic factors affecting epidermal penetration and percutaneous absorption

S. Riegelman, 1974, Clinical pharmacology and therapeutics.

Renal contribution to overall metabolism of drugs. 3. Metabolism of p-aminobenzoic acid.

S. Riegelman, S. H. Wan, B. von Lehmann, 1972, Journal of pharmaceutical sciences.

Improved high-performance liquid chromatographic assay for theophylline in plasma and saliva in the presence of caffeine and its metabolites and comparisons with three other assays.

S. Riegelman, K. Muir, M. Kunitani, 1982, Journal of chromatography.

Dose-dependent kinetics for theophylline: observations among ambulatory asthmatic children.

L. Hendeles, M. Weinberger, S. Riegelman, 1980, The Journal of pediatrics.

Fluorometric microassay for spironolactone and its metabolites in biological fluids.

W. Sadee, S. Riegelman, M. Dagcioglu, 1972, Journal of pharmaceutical sciences.

Plasma levels of spirolactones in the dog.

W. Sadee, S. Riegelman, S. Jones, 1972, Journal of pharmaceutical sciences.

Disposition of tritium-labeled spirolactones in the dog.

W. Sadee, S. Riegelman, S. Jones, 1972, Journal of pharmaceutical sciences.

Statistical estimations in pharmacokinetics

Harold G. Boxenbaum, Sidney Riegelman, Robert M. Elashoff, 1974, Journal of Pharmacokinetics and Biopharmaceutics.

Absorption characteristics of solid dispersed and micronized griseofulvin in man.

S. Riegelman, W. L. Chiou, 1971, Journal of pharmaceutical sciences.

The ultraviolet absorption spectrum as a criterion of the type of solubilization

S. Riegelman, L. Strait, M. Hrenoff, 1958 .

Renal contribution to overall metabolism of drugs. IV. Biotransformation of salicylic acid to salicyluric acid in man.

S. Riegelman, S. H. Wan, B. von Lehmann, 1972, Journal of pharmaceutical sciences.

Griseofulvin levels in stratum corneum. Study after oral administration in man.

V. Shah, S. Riegelman, W. Epstein, 1972, Archives of dermatology.

Determination of griseofulvin in skin, plasma, and sweat.

V. Shah, S. Riegelman, W. Epstein, 1972, Journal of pharmaceutical sciences.

Topically applied griseofulvin in prevention and treatment of Trichophyton mentagrophytes.

V. Shah, S. Riegelman, W. Epstein, 1975, Archives of dermatology.

Electron Capture Gas Chromatographic Assay for Miconazole and Clotrimazole In Skin Samples

V. Shah, S. Riegelman, S. Wallace, 1978 .

Role of sweat in accumulation of orally administered griseofulvin in skin.

V. Shah, S. Riegelman, W. Epstein, 1974, The Journal of clinical investigation.

Topically applied antifungal agents. Percutaneous penetration and prophylactic activity against trichophyton mentagrophytes infection.

V. Shah, S. Riegelman, S. Wallace, 1977, Archives of dermatology.

Increased dissolution rates of water-insoluble cardiac glycosides and steroids via solid dispersions in polyethylene glycol 6000.

S. Riegelman, W. L. Chiou, S Riegelman, 1971, Journal of pharmaceutical sciences.

Oral absorption of griseofulvin in dogs: increased absorption via solid dispersion in polyethylene glycol 6000.

S. Riegelman, W. L. Chiou, S Riegelman, 1970, Journal of pharmaceutical sciences.

Absorption and activity of some derivatives of griseofulvin.

S. Riegelman, L. J. Fischer, 1967, Journal of pharmaceutical sciences.

Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.

S. Riegelman, J. Loo, 1970, Journal of pharmaceutical sciences.

Griseofulvin-phenobarbital interaction in man.

M. Rowland, S. Riegelman, W. Epstein, 1970, JAMA.

Metabolism of griseofulvin in dogs.

S. Riegelman, P. Harris, 1969, Journal of pharmaceutical sciences.

Effects of potential inhibitors on metabolism of griseofulvin in vitro.

S. Kaplan, S. Riegelman, K. H. Lee, 1966, Journal of pharmaceutical sciences.

Absorption and Distribution of Griseofulvin in Rabbits

S. Riegelman, L. J. Fischer, 1965 .

Concept of a volume of distribution and possible errors in evaluation of this parameter.

M. Rowland, S. Riegelman, J. Loo, 1968, Journal of pharmaceutical sciences.

Quantitative determination of griseofulvin and griseofulvin-4'-alcohol in plasma by fluorimetry on thin layer chromatograms.

S. Riegelman, L. J. Fischer, 1966, Journal of chromatography.

GLC determination of theophylline in biological fluids.

V. Shah, S. Riegelman, V. P. Shah, 1974, Journal of pharmaceutical sciences.

Convenient and sensitive high-performance liquid chromatography assay for cimetidine in plasma or urine.

D. Johnson, S. Riegelman, R. Upton, 1981, Journal of chromatography.

Absorption kinetics of aspirin in man following oral administration of an aqueous solution.

M. Rowland, S. Riegelman, P. Harris, 1972, Journal of pharmaceutical sciences.

The clinical pharmacokinetics of phenytoin

L. Sheiner, T. Tozer, S. Riegelman, 1977, Journal of Pharmacokinetics and Biopharmaceutics.

Acid dissociation constants of phenylalkanolamines.

S. Riegelman, L. Strait, E. Fischer, 1962, Journal of Pharmacy and Science.

Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urine.

N. Holford, R. Williams, S. Riegelman, 1980, Journal of pharmaceutical sciences.

EFFECT OF IUDR AND AMETHOPTERIN ON EXPERIMENTAL HERPES SIMPLEX KERATITIS.

S. Riegelman, E. Jawetz, P. Thygeson, 1963, Investigative ophthalmology.

Toxicity studies on tannic acid administered by enema. I. Effects of enema-administered tannic acid on the colon and liver of rats.

P. A. Harris, A. Margulis, F. Zboralske, 1966, The American journal of roentgenology, radium therapy, and nuclear medicine.

Intestinal drug absorption and metabolism. I. Comparison of methods and models to study physiological factors of in vitro and in vivo intestinal absorption.

W. H. Barr, S. Riegelman, 1970, Journal of pharmaceutical sciences.

Pharmacokinetics of isoniazid and some metabolites in man

H. Boxenbaum, S. Riegelman, 1976, Journal of Pharmacokinetics and Biopharmaceutics.

New method for calculating the intrinsic absorption rate of drugs.

S. Riegelman, J. Loo, S Riegelman, 1968, Journal of pharmaceutical sciences.

A rational basis for the preparation of ophthalmic solutions.

S RIEGELMAN, D G VAUGHAN, S. Riegelman, 1958, Survey of ophthalmology.

Plasma and synovial fluid concentrations of acetylsalicylic acid in patients with rheumatoid arthritis.

S. Riegelman, E. Eyring, S. D. Sholkoff, 1967, Arthritis and rheumatism.

Pharmacokinetics of Acetylsalicylic Acid and Salicylic Acid After Intravenous Administration in Man

Malcolm Rowland, Sidney Riegelman, M. Rowland, 1968 .

Convenient and sensitive high-performance liquid chromatography assay for ketoprofen, naproxen and other allied drugs in plasma or urine.

R. Williams, S. Riegelman, T. Guentert, 1980, Journal of chromatography.

The application of statistical moment theory to the evaluation ofin vivo dissolution time and absorption time

P. Collier, S. Riegelman, 1980, Journal of Pharmacokinetics and Biopharmaceutics.

Improved liquid-chromatographic assay of quinidine and its metabolites in biological fluids.

N. Holford, S. Riegelman, A. Rakhit, 1982, Clinical chemistry.

Determination of quinidine and its major metabolites by high-performance liquid chromatography.

S. Riegelman, T. Guentert, R. Upton, 1979, Journal of chromatography.

Antibacterial agents in Pseudomonas aeruginosa contaminated ophthalmic solutions.

S RIEGELMAN, D G VAUGHAN, S. Riegelman, 1956, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

Gastrointestinal absorption of quinidine from some solutions and commercial tablets

N. Holford, A. Bostrom, S. Riegelman, 1980, Journal of Pharmacokinetics and Biopharmaceutics.

Quinidine pharmacokinetics in man: Choice of a disposition model and absolute bioavailability studies

N. Holford, S. Riegelman, T. Guentert, 1979, Journal of Pharmacokinetics and Biopharmaceutics.

Divergence in pharmacokinetic parameters of quinidine obtained by specific and nonspecific assay methods

N. Holford, S. Riegelman, T. Guentert, 1979, Journal of Pharmacokinetics and Biopharmaceutics.

Determination of quinidine and metabolites in urine by reverse-phase high-pressure liquid chromatography.

S. Riegelman, T. Guentert, R. Upton, 1979, Clinica chimica acta; international journal of clinical chemistry.

Induction of quinidine metabolism and plasma protein binding by phenobarbital in dogs

D. Effeney, N. Holford, S. Riegelman, 1984, Journal of Pharmacokinetics and Biopharmaceutics.

Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay

R. Williams, S. Riegelman, T. Guentert, 2004, European Journal of Clinical Pharmacology.

Dissolution rate studies. I. Design and evaluation of a continuous flow apparatus.

S. Riegelman, J. Tingstad, 1970, Journal of pharmaceutical sciences.

Microultrafiltration technique for drug-protein binding determination in plasma.

V. Shah, S. Riegelman, S. Wallace, 1974, Journal of pharmaceutical sciences.

Determination of picogram nitroglycerin plasma concentrations using capillary gas chromatography with on-column injection.

I. Kanfer, L. Benet, S. Riegelman, 1984, Journal of pharmaceutical sciences.

Physiological and pharmacokinetic complexities in bioavailability testing.

S. Riegelman, 1972, Pharmacology.

Evaluation of the absorption from some commercial sustained-release theophylline products

L. Sansom, J. Powell, S. Riegelman, 1980, Journal of Pharmacokinetics and Biopharmaceutics.

Evaluation of the absorption from some commercial enteric-release theophylline products

L. Sansom, J. Powell, S. Riegelman, 2005, Journal of Pharmacokinetics and Biopharmaceutics.

GLC analysis of acetazolamide in blood, plasma, and saliva following oral administration to normal subjects.

V. Shah, S. Riegelman, S. Wallace, 1977, Journal of pharmaceutical sciences.

Preliminary pharmacokinetic studies of propylthiouracil in humans

S. Riegelman, B. Lehmann, D. Schuppan, 1973, Journal of Pharmacokinetics and Biopharmaceutics.

The influence of bacterial gut hydrolysis on the fate of orally administered isonicotinuric acid in man

T. Macgregor, H. Boxenbaum, S. Riegelman, 1974, Journal of Pharmacokinetics and Biopharmaceutics.

An automated HPLC method for the assay of propranolol and its basic metabolites in plasma and urine.

S. Riegelman, B. Silber, M. Lo, 1982, Journal of chromatographic science.

Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia.

L B Sheiner, J R Powell, L. Sheiner, 1978, The American review of respiratory disease.

Altered protein binding of diphenylhydamtoin in uremic plasma.

C. E. Becker, S. Riegelman, M. Blum, 1972, The New England journal of medicine.

Nonlinear theophylline elimination

S. Riegelman, D. Tang-Liu, Roger L. Williams, 1982, Clinical pharmacology and therapeutics.

Changes in theophylline clearance during acute illness.

L. Sheiner, P. Hopewell, J. Powell, 1978, JAMA.

A new stabilized form of epinephrine for the treatment of open-angle glaucoma.

S. Riegelman, R. Shaffer, D. Vaughan, 1961, Archives of ophthalmology.

Stabilization of epinephrine against sulfite attack.

S. Riegelman, E. Fischer, 1962, Journal of pharmaceutical sciences.

Effect of boric acid and bisulfite on the rate of oxidation of epinephrine.

S. Riegelman, E. Fischer, 1962, Journal of pharmaceutical sciences.

Rate of sterilization as a factor in the selection of ophthalmic solutions; experimental studies with a proposed method of preparing sterile solutions.

S. Riegelman, M. Okumoto, D. Vaughan, 1955, A.M.A. archives of ophthalmology.

Kinetics of Acetylsalicylic Acid Disposition in Man

M. Rowland, S. Riegelman, P. Harris, 1967, Nature.

Toxicity studies on tannic acid administered by enema. 3. Studies on the retention of enemas in humans. IV. Review and conclusions.

P. A. Harris, A. Margulis, F. Zboralske, 1966, The American journal of roentgenology, radium therapy, and nuclear medicine.

The kinetics of rectal absorption. II. The absorption of anions.

S. Riegelman, W. Crowell, 1958, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

The kinetics of rectal absorption. III. The absorption of undissociated molecules.

S. Riegelman, W. Crowell, 1958, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

Phenol coefficients and the Ferguson principle.

S. Riegelman, N. Allawala, 1954, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

Two-compartment model for a drug and its metabolite: application to acetylsalicylic acid pharmacokinetics.

L. Benet, M. Rowland, S. Riegelman, 1970, Journal of pharmaceutical sciences.

Dose-dependent elimination of propranolol and its major metabolites in humans.

N. Holford, S. Riegelman, B. Silber, 1983, Journal of pharmaceutical sciences.

Complications in using rabbits for the study of oral drug absorption.

S. Riegelman, W. L. Chiou, J. Amberg, 1969, Chemical & pharmaceutical bulletin.

Assay forTotalBileSaltsin Bile

S. Riegelman, 1972 .

Effect of erythromycin on theophylline kinetics.

L. Hendeles, M. Weinberger, S. Riegelman, 1981, The Journal of allergy and clinical immunology.

Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions

D. Effeney, S. Pond, T. Tozer, 1984, Journal of Pharmacokinetics and Biopharmaceutics.

A technique to study hepatic and intestinal drug metabolism separately in the dog.

D. Effeney, S. Pond, S. Riegelman, 1982, The Journal of pharmacology and experimental therapeutics.

Lack of gastrointestinal metabolism of propranolol in dogs after portacaval transposition.

D. Effeney, S. Pond, S. Riegelman, 1982, The Journal of pharmacology and experimental therapeutics.

Determination of propranolol and its major metabolites in plasma and urine by high-performance liquid chromatography without solvent extraction.

S. Riegelman, M. Lo, 1980, Journal of chromatography.

Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria

V. Shah, L. Sansom, J. Powell, 1980, Journal of Pharmacokinetics and Biopharmaceutics.

Intraindividual variability in theophylline pharmacokinetics: Statistical verification in 39 of 60 healthy young adults

L. Sansom, J. Powell, S. Riegelman, 1982, Journal of Pharmacokinetics and Biopharmaceutics.

Estimation of absolute bioavailability assuming steady state apparent volume of distribution remains constant

P. Collier, S. Riegelman, 1983, Journal of Pharmacokinetics and Biopharmaceutics.

A method for estimating within-individual variability in clearance and in volume of distribution from standard bioavailability studies

S. Riegelman, R. Upton, J. Thiercelin, 1982, Journal of Pharmacokinetics and Biopharmaceutics.

Factors affecting the pharmacokinetics of theophylline.

S. Riegelman, K. Muir, R. Upton, 1980, European journal of respiratory diseases. Supplement.

The kinetics of rectal absorption. I. Preliminary investigations into the absorption rate process.

S. Riegelman, W. Crowell, 1958, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

Rapid spectrofluorometric assay for total bile salts in bile.

S. Riegelman, E. Mroszczak, 1972, Clinical chemistry.

Kinetics of drug-drug interactions: biliary excretion of iodoxamic acid and iopanoic acid in rhesus monkeys.

A. Moss, S. Riegelman, S. K. Lin, 1979, Journal of pharmaceutical sciences.

Disposition of diethylstilbestrol in the rhesus monkey

S. Riegelman, E. Mroszczak, 1975, Journal of Pharmacokinetics and Biopharmaceutics.

The effect of surfactants on drug stability. I.

S. Riegelman, 1960, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

Influence of allopurinol on theophylline disposition in adults

L. Sheiner, S. Vožeh, S. Riegelman, 1980, Clinical pharmacology and therapeutics.

RapidSpectrofluorometric Assay for Total BileSaltsin Bile

S. Riegelman, E. Mroszczak, 2004 .

Pharmacokinetics of quinidine and three of its metabolites in man

N. Holford, S. Riegelman, T. Guentert, 1984, Journal of Pharmacokinetics and Biopharmaceutics.

Specificity of quinidine determination methods.

S. Riegelman, T. Guentert, 1978, Clinical chemistry.

Use of carbon disulfide as a solvent for the silylation of submicrogram amounts of carboxylic acids.

M. Rowland, S. Riegelman, 1967, Analytical biochemistry.

Biliary excretion of diethylstilbestrol in the rhesus monkey

S. Riegelman, E. Mroszczak, 1978, Journal of Pharmacokinetics and Biopharmaceutics.